According to the parameters selected above, there are no articles from Pharmaceutical Product Development, LLC (PPD) from 1 March 2023 - 29 February 2024.

Pharmaceutical Product Development (PPD) has put an end to speculation about its future and joined the swelling ranks of contract research organisations putting their faith in private equity ...

Pharmaceutical Product Development, LLC (PPD), a global contract research organization (CRO), will invest $63.7 million to expand its bioanalytical lab in Henrico County, VA.

Healthcare research provider Pharmaceutical Product Development (PPD) (NASDAQ:PPDI) said on Monday that it has agreed to be acquired by private equity firms The Carlyle Group and Hellman ...

WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) today announced that Training magazine has named the company for the fifth consecutive year to its Top 125 list of ...

Carlyle Group is in exclusive discussions to buy drug research services provider Pharmaceutical Product Development (PPD), Bloomberg reports. Other bidders for the company included Blackstone ...

CRO Pharmaceutical Product Development (PPD) unveiled a number of new hires as part of the company’s goal to expand several therapeutics areas, including neuroscience, hematology/oncology, rare ...

US firm Pharmaceutical Product Development (PPD) is to create 250 jobs over the next five years at a new research facility in… David Labanyi Thu Dec 18 2008 - 00:00 ...

Pharmaceutical Product Development (PPD), has acquired Acurian, a service provider of clinical trial patient enrollment and retention solutions for the life sciences industry. Providing ...

Pharmaceutical Product Development, LLC (PPD) has announced that it has acquired RCT Logic’s exclusive license from Massachusetts General Hospital (MGH) for the portfolio of patents related to its ...